RG
Renaissance Group’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $676K | Sell |
1,519
-195
| -11% | -$86.8K | 0.03% | 173 |
|
|
2025
Q1 | $831K | Sell |
1,714
-1,468
| -46% | -$712K | 0.04% | 172 |
|
|
2024
Q4 | $1.28M | Sell |
3,182
-42
| -1% | -$16.9K | 0.05% | 167 |
|
|
2024
Q3 | $1.5M | Sell |
3,224
-70,255
| -96% | -$32.7M | 0.06% | 160 |
|
|
2024
Q2 | $34.4M | Sell |
73,479
-4,217
| -5% | -$1.98M | 1.34% | 19 |
|
|
2024
Q1 | $32.5M | Sell |
77,696
-11,236
| -13% | -$4.7M | 1.23% | 44 |
|
|
2023
Q4 | $36.2M | Sell |
88,932
-3,339
| -4% | -$1.36M | 1.5% | 10 |
|
|
2023
Q3 | $32.1M | Sell |
92,271
-1,660
| -2% | -$577K | 1.47% | 11 |
|
|
2023
Q2 | $33.1M | Sell |
93,931
-1,723
| -2% | -$606K | 1.43% | 20 |
|
|
2023
Q1 | $30.1M | Buy |
95,654
+50
| +0.1% | +$15.8K | 1.38% | 25 |
|
|
2022
Q4 | $27.6M | Sell |
95,604
-748
| -0.8% | -$216K | 1.35% | 33 |
|
|
2022
Q3 | $27.9M | Sell |
96,352
-9,916
| -9% | -$2.87M | 1.5% | 8 |
|
|
2022
Q2 | $29.9M | Sell |
106,268
-29,038
| -21% | -$8.18M | 1.55% | 5 |
|
|
2022
Q1 | $35.3M | Buy |
135,306
+10,191
| +8% | +$2.66M | 1.59% | 5 |
|
|
2021
Q4 | $27.5M | Buy |
125,115
+6,265
| +5% | +$1.38M | 1.12% | 48 |
|
|
2021
Q3 | $21.6M | Buy |
118,850
+17,365
| +17% | +$3.15M | 0.93% | 54 |
|
|
2021
Q2 | $20.5M | Sell |
101,485
-5,095
| -5% | -$1.03M | 0.86% | 54 |
|
|
2021
Q1 | $22.9M | Buy |
106,580
+23,538
| +28% | +$5.06M | 0.97% | 54 |
|
|
2020
Q4 | $19.6M | Buy |
83,042
+4,148
| +5% | +$980K | 0.84% | 54 |
|
|
2020
Q3 | $21.5M | Sell |
78,894
-589
| -0.7% | -$160K | 0.99% | 53 |
|
|
2020
Q2 | $23.1M | Buy |
+79,483
| New | +$23.1M | 1.1% | 47 |
|